Hodgkin’s Lymphoma Pipeline Therapies, Treatment, Drugs & Medicine and Key pharma players involved by DelveInsight | Affimed Therapeutics, ACD Therapeutics, Cstone Pharmaceuticals and Many Others

January 26 11:10 2022
Hodgkin’s Lymphoma Pipeline Therapies, Treatment, Drugs & Medicine and Key pharma players involved by DelveInsight | Affimed Therapeutics, ACD Therapeutics, Cstone Pharmaceuticals and Many Others
Hodgkin’s Lymphoma Pipeline

Hodgkin’s Lymphoma also known as Hodgkin’s disease is a type of blood cancer that initiate in the lymphatic system (part of immune system that help to get rid of waste and fight against infections). This disease is the most common type of cancer of lymphatic system. Hodgkin disease originate in the WBCs and grow abnormally and spread beyond the lymphatic system. As the disease progress it invades into other organs and can damage their function. Hodgkin’s lymphoma are more common in men than women and affect individuals between the age of 15-40 and above 55 years. The exact etiology of Hodgkin’s Lymphoma is not clear however, DNA mutation, and infection of Epstein-Barr virus (EBV), which causes mononucleosis can be the reason behind the development of Hodgkin’s lymphoma.

 

DelveInsight’s, “Hodgkin’s Lymphoma Pipeline Insight, 2021” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Hodgkin’s Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/hodgkins-lymphoma-pipeline-insight

 

Hodgkin’s Lymphoma Key Players

  • Affimed Therapeutics
  • ACD Therapeutics
  • Cstone Pharmaceuticals
  • 4SC
  • TG Therapeutics
  • And Many Others

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/hodgkins-lymphoma-pipeline-insight

 

DelveInsight’s Hodgkin’s Lymphoma report covers around 10+ products under different phases of clinical development like

  • Mid-stage products (Phase II and Phase I/II)
  • Early-stage products (Phase I/II and Phase I) along with the details of
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates

 

Some of Hodgkin’s Lymphoma Therapies are:

  • AFM 13
  • Camidanlumab tesirine
  • Sugemalimab
  • Resminostat
  • TGR-1202
  • And Many Others

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/hodgkins-lymphoma-pipeline-insight

 

Current Hodgkin’s Lymphoma Treatment Scenario and Hodgkin’s Lymphoma Emerging Therapies:

  • How many companies are developing Hodgkin’s Lymphoma drugs?
  • How many Hodgkin’s Lymphoma drugs are developed by each company?
  • How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Hodgkin’s Lymphoma?
  • What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Hodgkin’s Lymphoma therapeutics?
  • What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Hodgkin’s Lymphoma and their status?
  • What are the key designations that have been granted to the emerging drugs?

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/hodgkins-lymphoma-pipeline-insight

 

Table of Contents:

Introduction

Executive Summary

Hodgkin’s Lymphoma: Overview

  • Causes
  • Mechanism of Action
  • Signs and Symptoms
  • Diagnosis
  • Disease Management

Pipeline Therapeutics

  • Comparative Analysis

Therapeutic Assessment

  • Assessment by Product Type
  • Assessment by Stage and Product Type
  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

Hodgkin’s Lymphoma – DelveInsight’s Analytical Perspective

In-depth Commercial Assessment

  • Hodgkin’s Lymphoma companies’ collaborations, Licensing, Acquisition -Deal Value Trends

Hodgkin’s Lymphoma Collaboration Deals

  • Company-Company Collaborations (Licensing / Partnering) Analysis
  • Company-University Collaborations (Licensing / Partnering) Analysis

Mid Stage Products (Phase II)

  • Comparative Analysis

AFM 13:Affimed Therapeutics

  • Product Description
  • Research and Development
  • Product Development Activities

Drug profiles in the detailed report…..

Mid Stage Products (Phase II)

  • Comparative Analysis

Camidanlumab tesirine: ACD Therapeutics

  • Product Description
  • Research and Development
  • Product Development Activities

Drug profiles in the detailed report…..

Pre-clinical and Discovery Stage Products

  • Comparative Analysis
  • Product Description
  • Research and Development
  • Product Development Activities

Drug profiles in the detailed report…..

Inactive Products

  • Comparative Analysis

Hodgkin’s Lymphoma Key Companies

Hodgkin’s Lymphoma Key Products

Hodgkin’s Lymphoma- Unmet Needs

Hodgkin’s Lymphoma- Market Drivers and Barriers

Hodgkin’s Lymphoma- Future Perspectives and Conclusion

Hodgkin’s Lymphoma Analyst Views

Hodgkin’s Lymphoma Key Companies

Appendix

 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/hodgkins-lymphoma-pipeline-insight